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Introduction
Invading intracellular bacteria have to continuously battle with 
the host for survival. Therefore, it is not surprising that most 
bacterial pathogens have evolved fascinating mechanisms to 
subvert host cell defense mechanisms or exploit its nutrient in-
ventory. To do so, bacterial pathogens are armed with an arse-
nal of different virulence factors, called effectors, which can 
specifically manipulate cellular pathways to their advantage. As 
soon as a bacterial pathogen enters the host cell, the host tries to 
degrade the bacteria in the lysosome; thus, bacterial pathogens 
need to prevent, delay, or escape contact with lysosomes (Luzio 
et al., 2007). In addition, the pathogen encounters innate im-
mune signaling, which leads to a proinflammatory cytokine re-
sponse. Furthermore, intracellular bacteria must defend against 
autophagic clearance and activation of homeostatic pathways, 
such as the unfolded protein response (UPR), that can lead to 
apoptosis (Cemma and Brumell, 2012; Celli and Tsolis, 2015). 
Finally, the pathogen needs to build itself a replicative niche 
where it can acquire nutrients from the host; for many intra-
cellular pathogens, this niche is a subcellular membrane-bound 
compartment that is conducive to its replication (Kumar and 
Valdivia, 2009). How pathogens subvert membrane transport 
pathways has been extensively studied (Alix et al., 2011; Asrat 
et al., 2014a); therefore, in this review, we will focus on patho-
genic strategies that subvert key host defense mechanisms and 
manipulate host signaling pathways to create a suitable intra-
cellular niche. The innate immune response, the UPR pathway, 
and autophagy are central to host defense. However, they are 
also homeostatic pathways that can be exploited by intracel-
lular pathogens. Likewise, the means of transcriptional and 
posttranslational regulation of these pathways through his-
tone modifications and ubiquitination can also be co-opted by 
pathogens to manipulate the cell signaling pathways and gene 
expression of the host.
Sensing of bacterial colonization by the 
innate immune system
Innate immune cells have the remarkable ability to sense bac-
teria, both extracellularly and intracellularly, and mount an 
appropriate immune response that matches the level of threat 
(Akira et al., 2006). Pathogen recognition receptors (PRRs) rec-
ognize broadly conserved pathogen-associated molecular pat-
terns (PAMPs) and trigger multiple signaling pathways, which 
ultimately lead to changes in gene expression of proinflamma-
tory cytokines and genes that regulate antimicrobial processes 
(Akira et al., 2006). In addition, PRRs in the cytosol control 
potent antimicrobial responses including the inflammasome, 
Intracellular bacterial pathogens have developed versa-
tile strategies to generate niches inside the eukaryotic 
cells that allow them to survive and proliferate. Making a 
home inside the host offers many advantages; however, 
intracellular bacteria must also overcome many chal-
lenges, such as disarming innate immune signaling and 
accessing host nutrient supplies. Gaining entry into the 
cell and avoiding degradation is only the beginning of a 
successful intracellular lifestyle. To establish these replica-
tive niches, intracellular pathogens secrete various viru-
lence proteins, called effectors, to manipulate host cell 
signaling pathways and subvert host defense mecha-
nisms. Many effectors mimic host enzymes, whereas oth-
ers perform entirely novel enzymatic functions. A large 
volume of work has been done to understand how intra-
cellular bacteria manipulate membrane trafficking path-
ways. In this review, we focus on how intracellular 
bacterial pathogens target innate immune signaling, the 
unfolded protein response, autophagy, and cellular me-
tabolism and exploit these pathways to their advantage. 
We also discuss how bacterial pathogens can alter host 
gene expression by directly modifying histones or hijack-
ing the ubiquitination machinery to take control of sev-
eral host signaling pathways.
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autophagy, and the cytosolic surveillance pathway (CSP; 
Deretic and Levine, 2009; Lamkanfi and Dixit, 2011; Rado-
shevich and Dussurget, 2016). Finally, the proinflammatory 
cytokine response that is initiated by infected cells can also 
activate neighboring, uninfected bystander cells to mount a 
multicellular immune response to the threat (Holmgren et al., 
2017). Accordingly, successful bacterial pathogens attempt to 
usurp host innate immunity at all levels of defense (Reddick 
and Alto, 2014). Sensing the disruption to the cellular homeo-
stasis inflicted by bacterial effector proteins allows the host to 
Figure 1. Modulation of innate immunity signaling pathways by bacterial pathogens. (A) Stimulation of PRRs by PAMPs activates a MAPK signaling 
cascade. (B) PRR activation also releases NF-κB from its inhibitor, IκB, which allows NF-κB to translocate to the nucleus and induce the expression of 
proinflammatory cytokines. (C) STI NG, a major regulator of the CSP that is anchored to the ER, is activated by cyclic dinucleotides cGAMP produced by 
DNA sensing from cGAS as well as secreted c-di-AMP produced by bacteria. Activation of the STI NG/TBK1/IRF3 pathway leads to a type I IFN response. 
(D) Posttranslational modifications to histones by bacterial pathogens. Bacterial effectors can inhibit host-mediated histone modifications by indirectly 
causing the reversal of these modifications. Bacterial effectors can also directly modify histones. H, histones; red, inhibitory histone modifications; green, 
activating histone modifications; black, pathogen effector protein; italics, pathogen. Histone modifications: phosphorylation (p), acetylation (ac), methyl-
ation (me), dimethylation (me2), and trimethylation (me3). Bacteria or secreted bacterial effectors can either inhibit (red) or activate (green) these innate 
immune signaling pathways.
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discriminate between pathogens and nonpathogens (Vance et 
al., 2009). Pathogen recognition by the innate immune system 
has been extensively reviewed (Akira et al., 2006; Mogensen, 
2009; Vance et al., 2009); here, we will highlight more recent 
examples of modulation of innate immune signaling pathways 
by intracellular bacterial pathogens.
Innate immune signaling through PRRs. Host 
defense against bacterial pathogens greatly relies on PRRs 
that recognize specific PAMPs such as nucleic acids, cell wall 
components, and proteins from fungi, bacteria, viruses, and 
parasites. Two major PRR classes are Toll-like receptors 
(TLRs) and NOD-like receptors (NLRs), which collectively 
recognize PAMPs at the cell surface as well as in the cyto-
plasm (Mogensen, 2009). PAMP recognition by PRRs acti-
vates a proinflammatory response via two major signaling 
pathways that are mediated by MAPKs and nuclear factor-κB 
(NF-κB), respectively (Arthur and Ley, 2013; Fig. 1, A and B). 
Activated TLRs and NLRs associate with specific adapter pro-
teins and initiate MAPK signaling via downstream MAP3K, 
MAP2K, and MAPK phosphorylation cascades (Fig.  1  A). 
Three major MAPK families mediate pro-survival signaling 
pathways: extracellular signal-regulated kinases (ERKs), p38, 
and JNK. Stimulated PRRs at the cell surface and in the cyto-
plasm activate these MAPKs, which in turn activate cytoplas-
mic transcription factors that induce the expression of 
proinflammatory cytokines in the nucleus (Arthur 
and Ley, 2013; Fig. 1 A).
In addition to MAPK signaling, NF-κB is essential in reg-
ulating the innate immune response of the host and is activated 
downstream of most PRRs (Dev et al., 2010; Fig. 1 B). In the 
absence of infection, NF-κB is associated with the inhibitor of 
κB (IκB) in the cytoplasm. Activated PRRs recruit adapter pro-
teins, such as TNF receptor–associated factors (TRAFs), which 
activate IκB kinase protein complex (IKK). IKK phosphorylates 
IκB, which is subsequently ubiquitinated and proteosomally de-
graded. Released NF-κB is then able to enter the nucleus and 
induce the expression of proinflammatory proteins (e.g., TNF 
and IL-6; Hayden and Ghosh, 2008; Fig. 1 A).
A third major host defense against intracellular bacterial 
pathogens is the CSP, which recognizes hallmarks of infection, 
such as DNA in the cytoplasm, and induces a type I IFN response 
(O’Riordan et al., 2002; Fig. 1 C). Stimulator of interferon genes 
(STI NG) is a major player in the CSP (Ishikawa and Barber, 
2008). STI NG activates TANK-binding kinase 1 (TBK1), which 
phosphorylates IFN regulatory factor 3 (IRF3) and induces IFN 
expression (Radoshevich and Dussurget, 2016). The cytosolic 
DNA sensor, cyclic GMP-AMP synthase (cGAS), can activate 
STI NG by producing the second messenger, 2′3′-cyclic guano-
sine monophosphate–adenosine monophosphate (cGAMP; Sun 
et al., 2013). Cyclic dinucleotides (CDNs) produced by bacteria 
can also activate the STI NG/TBK1/IRF3 pathway and induce 
an IFN response in the host independently of cGAS (Burdette 
et al., 2011; Sauer et al., 2011; Fig. 1 C).
The diversity of PRRs, PRR ligands, and PRR adapter pro-
teins allows for a specific and highly regulated innate immune 
response to pathogen invasion. The target, degree, and timing 
of gene expression are finely tuned to the specific PRR–PAMP 
interactions, which activate different subsets of transcription 
factors (Dev et al., 2010). More importantly, MAPK-, NF-κB–, 
and CSP-mediated transcriptional programs can synergize upon 
activation of distinct PRRs to mount an inflammatory response 
that is appropriate for a given pathogen (Akira et al., 2006).
Cytosolic sensors of intracellular pathogens. 
Three recent studies identified cGAS as a major host sensor of 
Mycobacteria tuberculosis (Mtb) DNA that is responsible for 
inducing a robust IFN response in the host during Mtb infection 
(Collins et al., 2015; Wassermann et al., 2015; Watson et al., 
2015; Fig. 1 C). The IFN response induced by wild-type Mtb is 
cGAS-dependent and activates IRF3 through the STI NG/
TBK1/IRF3 signaling pathway (Manzanillo et al., 2012; Col-
lins et al., 2015; Wassermann et al., 2015; Watson et al., 2015). 
The ESX-1 secretion system of Mtb is required to produce an 
Table 1. Glossary of effectors: Bacterial modulation of innate immunity
Bacteria Effector Host target Target pathways Outcome Mode of action Reference
L. pneumophila Lgt1, Lgt2, Lgt3 eEF1A Protein translation Inhibition of protein translation; 
enhanced immune response
Glucosyltransferase Belyi et al., 2006, 2008; 
Fontana et al., 2011, 2012
C. difficilea TcdA Unknown Unknown Enhanced immune response Glucosyltransferase Cowardin et al., 2016
P. aeruginosaa ToxA Unknown Protein translation Enhanced immune response AB exotoxin Dunbar et al., 2012; 
McEwan et al., 2012
Y. pestisa YopJ MAP2Ks MAPK Inhibits MAPK and NF-κB 
signaling
Serine/threonine 
acetyltransferase
Orth et al., 1999
IKK NF-κB Mukherjee et al., 2006
TAK1 (MAP3K) NF-κB Paquette et al., 2012
S. typhimurium AvrA MAP2Ks MAPK Inhibits apoptosis Serine/threonine 
acetyltransferase
Jones et al., 2008; Wu et 
al., 2012
L. monocytogenes InlC IKK NF-κB Reduces degradation of IκB Binds IKK Gouin et al., 2010
S. flexneri IpaH1.4 LUB AC NF-κB Inhibits the activation of IKK E3 ubiquitin ligase de Jong et al., 2016
S. flexneri IpaH2.5 LUB AC NF-κB Inhibits the activation of IKK E3 ubiquitin ligase de Jong et al., 2016
S. flexneri IpaH9.8 IKK NF-κB Proteasomal degradation 
of IKK
E3 ubiquitin ligase Ashida et al., 2010
S. flexneri OspG E2 ubiquitin-con-
jugating enzyme
NF-κB Inhibits the degradation 
of IκB
Kinase Kim et al., 2005; Zhou et al., 
2013; Pruneda et al., 2014
S. flexneri OspI Ubc13 (E2 ubiquitin- 
conjugating enzyme)
NF-κB Inactivates Ubc13 to prevent 
the activation of TRAF6
Glutamine 
deamidase
Sanada et al., 2012
S. enterica SpvD Xpo2 (nuclear exportin) NF-κB Reduces nuclear transport 
of NF-κB
Cysteine protease Grabe et al., 2016; Rolhion 
et al., 2016
aExtracellular pathogen.
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IFN response in the host and allows for Mtb DNA to be trans-
ferred into the host cytosol (Stanley et al., 2007; Manzanillo et 
al., 2012). cGAS binds mycobacterial DNA and colocalizes 
with Mtb-containing phagosomes as well as components of the 
host autophagy machinery (e.g., microtubule-associated protein 
1A/1B-light chain 3 [LC3] and Beclin1); interestingly, chemi-
cal inhibition of autophagy interferes with cGAS localization to 
Mtb-containing phagosomes (Wassermann et al., 2015; Watson 
et al., 2015). Consistent with the role of cGAS in targeting Mtb 
for autophagy and lysosomal degradation, cGAS- and 
STI NG-deficient bone marrow–derived macrophages show re-
duced colocalization of autophagy markers (e.g., LC3) with 
Mtb-containing phagosomes and have an increased bacterial 
load 5 d postinfection (Watson et al., 2015).
STI NG is also activated by CDNs that are produced 
by bacteria (Burdette et al., 2011; Sauer et al., 2011). Both 
Listeria monocytogenes and Chlamydia trachomatis acti-
vate STI NG directly by secreting cyclic-di-AMP to induce a 
cGAS-independent IFN response (Woodward et al., 2010; 
Barker et al., 2013; Webster et al., 2017; Fig.  1  C). STI NG, 
as well as a recently discovered host protein, reductase con-
trolling NF-κB (REC ON), can bind to cyclic di-AMP and acti-
vate NF-κB independently of each other (Abe and Barber, 2014; 
McFarland et al., 2017). Whereas STI NG is a positive regula-
tor of NF-κB that is activated by cyclic di-AMP, REC ON is a 
negative regulator of NF-κB that is inhibited by cyclic di-AMP 
(McFarland et al., 2017). Despite the role of STI NG in innate 
immunity, STI NG-deficient mice do not display an increase in 
bacterial load or susceptibility to L. monocytogenes (Sauer et 
al., 2011; Collins et al., 2015). However, the cyclic di-AMP 
secreted by L.  monocytogenes negatively impacts the T cell–
mediated adaptive immune response to subsequent infections 
(Archer et al., 2014). Together, these studies highlight how cy-
tosolic surveillance systems can also be modulated by bacterial 
metabolites and, in some cases, such as with L. monocytogenes, 
can dampen the host immune response.
Sensing of effector activity. In addition to PAMP 
recognition by PRRs, there is evidence to suggest that innate 
immune signaling pathways can recognize the enzymatic activ-
ity of certain bacterial effectors (Table 1). This phenomenon, 
termed effector-triggered immunity, was first described for 
plant–microbe interactions, whereby plants recognize patho-
gen-secreted effector proteins that suppress the initial 
PAMP-triggered immune response and counteract them by 
sending out an amplified, hypersensitive cell death response at 
the site of infection (Jones and Dangl, 2006). A similar exagger-
ated immune response to effector activity has been observed in 
the host response to infection by Legionella pneumophila. 
L. pneumophila uses a Dot/Icm type IV secretion system (T4SS) 
to deliver more than 300 effectors into the host cytosol during 
infection. Macrophages infected with wild-type L. pneumoph-
ila exhibit an exaggerated proinflammatory cytokine response 
in comparison to macrophages that are infected with the 
isogenic L.  pneumophila ΔdotA strain, which lacks a T4SS 
(Shin et al., 2008). Although the majority of cytokines are pro-
duced through canonical TLR and NLR signaling pathways, the 
enhanced expression of certain proinflammatory cytokine genes 
(e.g., IL-23a, Gem, and Csf2) does not occur in macrophages 
that are infected with an L. pneumophila strain that lacks a set 
of five effectors (Δ5) that inhibit protein translation in the host 
(Fontana et al., 2011). This set of effectors includes three Legio-
nella glucosyltransferase (Lgt) enzymes, which glucosylate and 
inactivate eukaryotic elongation factor 1A (eEF1A) in the host 
to inhibit translation (Belyi et al., 2006, 2008). Complementing 
the Δ5 strain with wild-type Lgt effectors, but not with catalyti-
cally dead versions of these Lgt effectors, restores the enhanced 
cytokine expression in macrophages, suggesting that the in-
duced inflammatory response depends on the glucosyltransfer-
ase activity of these Lgt effectors (Fontana et al., 2011, 2012). 
Likewise, enhanced cytokine expression is also restored in the 
Δ5 strain with chemical inhibitors of protein translation (Fon-
tana et al., 2011). Inhibiting protein synthesis results in pro-
longed activation of NF-κB by preventing the resynthesis of IκB 
(Fontana et al., 2011). The production of a subset of cytokines 
despite a global block in protein translation can be explained by 
the superinduction of specific cytokine transcripts when transla-
tion is inhibited; however, the details of the specific immune 
response pathways impacted by blocking translation remain to 
be explored (Barry et al., 2017). Interestingly, an enhanced im-
mune response to Clostridium difficile is also dependent on the 
glucosyltransferase activity of the C. difficile effector, toxin A 
(TcdA); however, the effect of TcdA on protein translation is 
unknown (Cowardin et al., 2016). Similarly, inhibition of pro-
tein translation by the AB exotoxin (ToxA) of the extracellular 
pathogen Pseudomonas aeruginosa triggers the induction of a 
subset of immune responses in Caenorhabditis elegans (Dunbar 
et al., 2012; McEwan et al., 2012). Perturbing cellular homeo-
stasis with specific effectors distinguishes pathogenic bacteria 
from commensal, nonpathogenic bacteria; therefore the ability 
to recognize the activity of pathogenic virulence factors serves 
an important role in host defense.
Bystander activation. Infected host cells can also 
signal to neighboring, uninfected cells to mount a proinflamma-
tory cytokine response to assist in clearing infections by intra-
cellular bacterial pathogens. This phenomenon, termed 
“bystander activation,” has become increasingly important in 
understanding how multicellular organisms fight against micro-
bial pathogens in the face of effector-mediated innate immune 
evasion (Holmgren et al., 2017). Uninfected bystander cells can 
respond to several signals that are emitted from infected cells, 
including reactive oxygen species (ROS), small molecules, 
PAMPs, and proinflammatory cytokines. For example, ROS in-
termediates produced by cells infected with L. monocytogenes 
can activate bystander cells to make proinflammatory CXCL2 
and CXCL5 chemokines (Dolowschiak et al., 2010). Mycobac-
terium-infected macrophages are unable to produce the p40 
subunit of IL-12 (IL-12p40) but release exosomes containing 
PAMPs to induce the production of IL-12p40 in bystander cells 
(Bhatnagar et al., 2007; Walters et al., 2013). As previously 
mentioned, effectors of L. pneumophila such as the Lgts target 
the host protein translation machinery, resulting in a major 
blockade in proinflammatory cytokine expression in infected 
host cells (Shin et al., 2008; Fontana et al., 2011, 2012; Table 1). 
However, by increasing the transcription of specific cytokines, 
the cells that are infected with L. pneumophila are able to over-
come the global block in translation and produce a limited num-
ber of cytokines (e.g., IL-1α and IL-1β; Barry et al., 2017). 
These specific cytokines activate bystander cells to produce 
several of the cytokines that the infected cell cannot (i.e., IL-6 
and IL-12; Asrat et al., 2014b; Copenhaver et al., 2015). By-
stander cells can also be activated by small molecules (e.g., 
cGAMP or Ca2+) that signal through gap junctions or by se-
creted macromolecules (e.g., inflammasomes or bacterial outer 
membrane vesicles; Holmgren et al., 2017). For example, the 
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cGAMP produced by cGAS activation appears to function in 
bystander activation. Although monocultures of cGAS-deficient 
or STI NG-deficient macrophages each have a reduced IFN re-
sponse to infection with wild-type M.  tuberculosis, infecting 
mixed cultures of these mutant cell lines partially restores IFN 
production (Wassermann et al., 2015). Furthermore, the partial 
restoration of the IFN response in mixed cultures is blocked by 
chemically inhibiting gap junction formation (Wassermann et 
al., 2015). In some cases, the signaling molecule for bystander 
activation is still unknown. For example, Shigella flexneri 
dampens the expression of IL-8 in infected host cells; however, 
MAPK-mediated IL-8 production is activated in neighboring, 
uninfected cells (Kasper et al., 2010). MAPKs (i.e., JNK, ERK, 
and p38) are activated in bystander cells in response to an un-
known NOD1 activation signal that is transmitted through gap 
junctions, and IL-8 is produced by bystander cells in response 
to infections from several different bacterial pathogens (e.g., 
S.  flexneri, L.  monocytogenes, and Salmonella typhimurium; 
Kasper et al., 2010). Overall, bystander activation represents an 
important counterattack to effector-mediated inhibition of 
proinflammatory cytokine expression.
Bacterial inhibition of innate immunity
Inhibition of MAPK- and NF-κB–mediated proinflammatory 
responses that are activated downstream of TLRs and NLRs 
is a crucial survival strategy for bacterial pathogens (Fig. 1, A 
and B). As such, bacterial pathogens secrete effectors that ei-
ther mimic host enzymes or use completely novel enzymatic 
activity to block innate immunity signaling (Table 1). The ex-
tracellular pathogen Yersinia pestis secretes a multifunctional 
enzyme, YopJ, that has serine/threonine acetyltransferase activ-
ity that inhibits several players of the MAPK and NF-κB sig-
nal transduction pathways (Orth et al., 1999; Mukherjee et al., 
2006, 2008; Paquette et al., 2012; Fig. 1, A and B). Similarly, 
S.  typhimurium secretes an acetyltransferase effector, AvrA, 
that is homologous to YopJ, which also targets MAPK signal-
ing; however, rather than dampening proinflammatory cytokine 
expression, AvrA inhibits apoptosis to prolong host survival 
(Jones et al., 2008; Wu et al., 2012; Fig. 1 A). Both S. flexneri 
and S. typhimurium secrete effectors that block the MAPK-me-
diated proinflammatory cytokine response by dephosphorylat-
ing p38 and ERK MAPKs in the nucleus (Arbibe et al., 2007; 
Li et al., 2007; Zhu et al., 2007; Haneda et al., 2012; Fig. 1 A). 
Finally, L. monocytogenes effector internalin C (InlC) directly 
interacts with IKK to reduce the phosphorylation and subse-
quent degradation of IκB, thereby suppressing the activation of 
NF-κB (Gouin et al., 2010; Fig. 1 B). Infection with L. mono-
cytogenes inlC mutants results in an increased proinflammatory 
response in macrophages as well as in mice (Gouin et al., 2010).
Bacterial pathogens modulate the ubiquitination of both 
positive and negative regulators of NF-κB to suppress the ac-
tivation of NF-κB and the transcription of NF-κB–responsive 
genes. S.  flexneri secretes multiple effectors (i.e., IpaH9.8, 
IpaH1.4, IpaH2.5, OspI, and OspG) that target the ubiquitination 
machinery of the host and block NF-κB activation (Fig. 1 B). 
For example, S. flexneri secretes an E3 ligase effector, IpaH9.8, 
that mimics host E3 ubiquitin ligases to target IKK, a critical 
activator protein complex of NF-κB, for proteasomal degrada-
tion (Ashida et al., 2010). S. flexneri secretes two additional E3 
ligase effectors, IpaH1.4 and IpaH2.5, that target an essential 
subunit of the linear ubiquitin chain assembly complex (LUB 
AC) for proteasomal degradation and suppress the activation of 
NF-κB (de Jong et al., 2016). LUB AC is a multimeric, host E3 
ubiquitin ligase that normally activates IKK with methionine 
1–linked linear ubiquitin chains (Walczak et al., 2012). Another 
S. flexneri effector, OspI, is a glutamine deamidase that inacti-
vates the E2 ubiquitin-conjugating enzyme Ubc13 and prevents 
the activation of the upstream regulator of NF-κB, TRAF6 
Table 2. Glossary of effectors: Histone modifications by bacterial virulence factors
Bacteria Effector Host target Target pathways Outcome Mode of action Reference
L. monocytogenes LLO Unknown Unknown Dephosphorylation of H3S10; 
deacetylation of H4
Cholesterol-dependent 
cytolysin pore-forming 
toxin
Hamon et al., 2007
L. monocytogenes InlB SIRT2 PI3K/AKT Deacetylation of H3K18 Binds to the cell surface 
receptor c-Met
Eskandarian et al., 
2013
S. flexneri OspF ERK and p38 
(MAPKs)
MAPK Dephosphorylation of H3S10 Phosphothreonine lyase Arbibe et al., 2007;  
Li et al., 2007;  
Zhu et al., 2007
S. typhimurium SpvC ERK (MAPKs) MAPK Dephosphorylation of MAPKs Phosphothreonine lyase Li et al., 2007;  
Zhu et al., 2007; 
Haneda et al., 2012
C. trachomatis NUE Histones H2B, 
H3, and H4
Direct PTMa Transcriptional repression Methyltransferase Pennini et al., 2010
L. pneumophila Paris RomA Histone H3 Direct PTM Methylation of H3K14; 
transcriptional repression
Methyltransferase Rolando et al., 2013
L. pneumophila 
Philadelphia LP02
LegAS4 Histone H3 Direct PTM Methylation of H3K4; 
transcriptional activation of 
ribosomal RNA genes
Methyltransferase Li et al., 2013
B. anthracisb BaSET Histone H1 Direct PTM; NF-κB Trimethylation of histone H1; 
transcriptional repression of 
NF-κB target genes
Methyltransferase Mujtaba et al., 2013
M. tuberculosis Rv1988 Histone H3 Direct PTM Dimethylation of histone H3R42; 
transcriptional repression of genes 
involved in ROS production
Methyltransferase Yaseen et al., 2015
aPTM, posttranslational modification.
bExtracellular pathogen.
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(Sanada et al., 2012; Fig. 1 B). Finally, OspG interferes with 
NF-κB activation by preventing the degradation of IκB (Kim 
et al., 2005; Zhou et al., 2013; Fig. 1 B). OspG binds to both 
ubiquitin and the E2-ubiquitin conjugating enzymes, which al-
losterically activates the OspG kinase domain and is required to 
block IκB degradation (Kim et al., 2005; Zhou et al., 2013; Pru-
neda et al., 2014). S. flexneri OspG mutants induce a stronger 
inflammatory response than wild-type S. flexneri because they 
are unable to prevent the dissociation of NF-κB from IκB (Kim 
et al., 2005; Zhou et al., 2013).
The translocation of NF-κB to the nucleus depends on 
the proper recycling of nuclear proteins, a process that is fa-
cilitated by importins and exportins, which shuttle proteins in 
and out of the nucleus, respectively. An imbalance of importin/
exportin shuttling disrupts NF-κB transport into the nucleus 
(Rolhion et al., 2016). The S.  typhimurium–secreted effector 
SpvD binds the nuclear exportin, Xpo2, which results in the 
accumulation of importin-α in the nucleus and reduces transport 
of NF-κB to the nucleus (Rolhion et al., 2016; Fig. 1 B). The 
crystal structure and mutational analysis of SpvD suggest that 
SpvD is a cysteine protease; however, exactly how this protease 
function negatively regulates NF-κB signal transduction is still 
unknown (Grabe et al., 2016). Overall, many intracellular bac-
terial pathogens secrete effectors that target MAPK and NF-κB 
signaling pathways to counteract the deleterious output of these 
host defense pathways and prevent downstream proinflamma-
tory cytokine expression.
Histone modifications by bacterial 
virulence factors
MAPK-mediated innate immune signaling pathways also intro-
duce or remove posttranslational modifications onto histones to 
change the chromatin structure and facilitate the transcription 
of proinflammatory cytokines. In eukaryotes, DNA is packaged 
into nucleosomes, which consist of an octamer of core histones 
(i.e., H2A, H2B, H3) that are linked together by histone H1 into 
higher-order assemblies (Luger et al., 1997; Fig.  1  D). Post-
translational modifications to histones (e.g., methylation, phos-
phorylation, acetylation, and ubiquitination) greatly impart an 
additional level of transcriptional regulation by dictating the ac-
cessibility of transcriptional activators and repressors to a given 
promoter. For example, MAPK-mediated phosphorylation of 
serine 10 on histone H3 (H3S10) increases the accessibility of 
NF-κB to the promoters of certain cytokines, including IL-8; in 
fact, global increase in phosphorylation of H3S10 is observed 
when cells are exposed to even LPS alone (Saccani et al., 2002). 
However, several intracellular bacterial pathogens secrete effec-
tors that can counteract host histone modifications to dampen 
the expression of proinflammatory cytokines (Table 2).
Histone modifications via innate immune sig-
naling pathways. L. monocytogenes induces a proinflamma-
tory cytokine response upon infection via canonical 
MAPK-mediated histone modifications (i.e., phosphorylation 
of H3S10) at the promoter regions of NF-κB regulated genes 
(i.e., IL-8; Schmeck et al., 2005; Opitz et al., 2006; Hamon et 
al., 2007). However, L.  monocytogenes is able to quickly 
dampen the host immune response by dephosphorylating 
H3S10 (Hamon et al., 2007). In addition, L.  monocytogenes 
also globally deacetylates H3 and H4 (Hamon et al., 2007; 
Fig. 1 D). The dephosphorylation of H3S10 and deacetylation 
of H4 are dependent on the L. monocytogenes–secreted viru-
lence factor listeriolysin O (LLO; Hamon et al., 2007; Fig. 1 D). 
In the presence of LLO, specific proinflammatory genes (i.e., 
cxcl2 and dusp4) are transcriptionally down-regulated and show 
reduced levels of both phosphorylated H3S10 and acetylated 
H4 (Hamon et al., 2007). Therefore, it appears that LLO-induced 
histone modifications impart a specific transcriptional response 
in the host. Interestingly, H3S10 dephosphorylation by L. mono-
cytogenes does not depend on its ability to enter the cell or to 
damage the cell membrane; however, it does depend on the 
membrane-binding ability of LLO, suggesting that LLO possi-
bly modulates host signal transduction pathways to induce his-
tone modifications (Hamon et al., 2007). LLO is a member of a 
family of cholesterol-dependent cytolysin pore-forming toxins 
that is shared by other bacterial pathogens. Remarkably, puri-
fied cholesterol-dependent cytolysin toxins from two different 
extracellular pathogens, Clostridium perfringens and Strepto-
coccus pneumonia, also reduced the levels of global H3S10 to a 
similar extent as LLO, which suggests that other bacterial 
pathogens possess the ability to epigenetically modulate host 
gene expression by altering histone modifications in a similar 
way (Hamon et al., 2007). Another L. monocytogenes effector, 
internalin B (InlB), also induces deacetylation of histone 3 on 
lysine 18 (H3K18) by activating a host histone deacetylase, sir-
tuin 2 (SIRT2; Eskandarian et al., 2013; Fig. 1 D). Deacetyla-
tion and occupancy by SIRT2 at transcriptional start sites of 
many genes involved in immune response regulation correlated 
with the transcriptional repression during L. monocytogenes in-
fection (Eskandarian et al., 2013). Likewise, the loss or inhibi-
tion of SIRT2 greatly attenuates infection by L. monocytogenes 
(Eskandarian et al., 2013).
S.  flexneri also inhibits MAPK signaling pathways to 
alter the epigenetic control of cytokine expression. S. flexneri 
secretes a unique phosphothreonine lyase effector, OspF, which 
dephosphorylates MAPKs (i.e., p38 and ERK) in the nucleus 
(Fig. 1 A). MAPK inactivation by OspF, in turn, reduces phos-
phorylation of H3S10 at the promoters of NF-κB regulated 
genes (e.g., IL-8) and attenuates the binding of NF-κB to these 
promoters (Arbibe et al., 2007; Fig.  1  D). Unlike traditional 
phosphatases, OspF irreversibly dephosphorylates host MAPKs 
using a phosphothreonine lyase mechanism that has not yet been 
described for any eukaryotic host enzymes; therefore, it rep-
resents an irreversible catalytic mechanism used by a bacterial 
pathogen to target host MAPKs and inflict effector-mediated 
inhibition of host immunity (Li et al., 2007; Zhu et al., 2007). 
S. typhimurium also secretes a similar phosphothreonine lyase 
effector, SpvC, which dephosphorylates a MAPK (i.e., ERK) to 
reduce inflammation and promote bacterial replication in vivo 
(Li et al., 2007; Zhu et al., 2007; Haneda et al., 2012; Fig. 1 A).
Direct modification of histones by secreted 
effectors. Recently, several bacterial methyltransferases 
have been identified that can localize to the nucleus and methyl-
ate mammalian host histones (Table 2). These bacterial methyl-
transferases share a conserved SET domain, which catalyze the 
attachment of a methyl group onto lysine residues of histones 
using a S-adenosyl-l-methionine (SAM) methyl donor. The 
first bacterial histone lysine methyltransferase (HKMT) effec-
tor was discovered in C. trachomatis and termed nuclear effec-
tor (NUE; Pennini et al., 2010). NUE is secreted by the 
C. trachomatis type III secretion system (T3SS) and localizes to 
the host cell nucleus. Interestingly, NUE exhibits automethyla-
tion activity, which improves its ability to methylate H2B, H3, 
and H4 in vitro (Pennini et al., 2010; Fig. 1 D). L. pneumophila 
Paris and L.  pneumophila Philadelphia Lp02 strains possess 
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homologous HKMT effectors, RomA and LegAS4, respec-
tively, which exert a strain-dependent phenotype on the host (Li 
et al., 2013; Rolando et al., 2013). Although both effectors 
methylate H3 to alter host transcription, they target distinct res-
idues. RomA localizes to the nucleus and methylates histone 3 
lysine 14 (H3K14), which results in global transcriptional re-
pression (Rolando et al., 2013; Fig. 1 D). H3K14 histone meth-
ylation is a novel epigenetic mark that appears to compete with 
H3K14 histone acetylation of the mammalian host (Rolando et 
al., 2013). In contrast, LegAS4 localizes to the nucleolus and 
methylates histone 3 lysine 4 (H3K4), which results in increased 
transcription of ribosomal RNA genes (rDNA; Li et al., 2013; 
Fig. 1 D). It is worth noting that an increase in H3K14 methyl-
ation is also observed by immunofluorescence upon infection 
with wild-type L.  pneumophila Philadelphia Lp02; however, 
whether H3K14 methylation depends on LegAS4 remains to be 
determined (Rolando et al., 2013). Many bacterial pathogens 
contain HKMT homologues in their effector repertoire, sug-
gesting that histone methylation might be a widespread strategy 
to take advantage of host transcription (Li et al., 2013). For 
Figure 2. Modulation of the UPR by bacterial pathogens. The UPR is mediated by three major sensors in the ER: IRE1, PERK, and ATF6. In the presence 
of unfolded proteins, the ER resident chaperone, BiP, dissociates from these UPR sensors, which contributes to their activation and downstream cellular re-
sponses, which include expression of protein chaperones and ERAD. Bacterial pathogens both activate (green) and inhibit (red) all three branches of the UPR.
Table 3. Glossary of effectors: Bacterial modulation of the UPR
Bacteria Effector Host target Target pathways Outcome Mode of action Reference
B. melitensis TcpB Unknown ATF6, PERK, IRE1 Activation of the UPR Unknown Smith et al., 2013
B. abortus VceC BiP IRE1 Activation of the UPR Unknown de Jong et al., 2013; 
Keestra-Gounder et al., 2016
L. monocytogenes LLO Unknown ATF6, PERK, IRE1 Activation of the UPR Unknown Pillich et al., 2012
L. pneumophila Lgt1, Lgt2, Lgt3 Unknown IRE1 Inhibition of XBP1u 
mRNA splicing
Glucosyltransferase Hempstead and Isberg, 2015;  
Treacy-Abarca and 
Mukherjee, 2015
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example, a SET domain containing an effector protein was re-
cently identified in Bacillus anthracis (BaSET), an extracellular 
bacterial pathogen that specifically trimethylates histone H1, 
but not the core histones (H2A, H2B, H3, and H4) in vitro (Mu-
jtaba et al., 2013; Fig.  1  D). Deleting BaSET renders B.  an-
thracis avirulent, and transient overexpression of BaSET in 
mammalian cells was capable of repressing the expression of 
NF-κB and NF-κB target genes (Mujtaba et al., 2013). Finally, 
M. tuberculosis secretes an effector methyltransferase, Rv1988, 
which dimethylates histone H3 on arginine 42 (H3R42me2) to 
repress the transcription of genes involved in producing ROS 
(Yaseen et al., 2015; Fig. 1 D). Because ROS production is a 
crucial host defense against bacterial pathogens, it is not sur-
prising that deleting rv1988 from M.  tuberculosis attenuates 
bacterial survival in host macrophages (Yaseen et al., 2015). 
Unlike most known regulatory histone modifications, this mod-
ification does not occur on the N termini of histones, but rather 
on a histone residue that is critical for DNA entry/exit from the 
nucleosome. Thus, Rv1988 is a novel virulence factor that im-
parts a noncanonical histone modification to modulate host im-
munity. Overall, by altering posttranslational modifications on 
histones via either MAPK signaling pathways or molecular 
mimicry, intracellular bacterial pathogens can inhibit the proin-
flammatory response of the host and manipulate host gene ex-
pression to their advantage.
Intracellular bacteria modulate the UPR
The UPR. Precise quality control of protein synthesis ascer-
tains that only correctly folded proteins exit the ER (Schwarz 
and Blower, 2016). If cellular homeostasis is disturbed by phys-
iological stress (e.g., DNA damage, chemical stimuli, or patho-
gen infection), misfolded and unfolded proteins accumulate in 
the lumen of the ER and cause ER stress. As a response, an 
evolutionarily conserved signaling network, the UPR pathway, 
is activated to alleviate this imbalance and restore ER homeo-
stasis. The UPR pathway down-regulates overall protein trans-
lation, induces ER-associated protein degradation (ERAD) of 
aberrantly folded proteins, and increases the synthesis of chap-
erones responsible for protein folding (Walter and Ron, 2011). 
The UPR is controlled by a set of three transmembrane 
ER-resident proteins: inositol-requiring protein 1 (IRE1), PKR-
like ER kinase (PERK), and activating transcription factor 6 
(ATF6; Fig.  2). Under unstressed conditions, the luminal do-
mains of these three sensors are stably bound to the ER chaper-
one immunoglobulin binding protein (BiP), which dissociates 
from its partners during ER stress, contributing to their activa-
tion (Gardner et al., 2013).
IRE1 is an ER transmembrane kinase that, upon sensing 
ER stress, oligomerizes and autophosphorylates to activate its 
RNase domain. The RNase domain is located on the cytosolic 
surface and targets X-box–binding protein 1 mRNA (XBP1u), 
resulting in spliced XBP1 mRNA (XBP1s). XBP1s mRNA en-
codes a transcription factor that is responsible for up-regulating 
UPR target genes that foster ERAD and enhance overall ER 
protein folding capacity (Cox and Walter, 1996; Yoshida et al., 
2001; Korennykh et al., 2009). Similar to IRE1, PERK is also 
an ER transmembrane kinase that oligomerizes and autophos-
phorylates upon activation. Activated PERK phosphorylates 
the α-subunit of the eukaryotic initiation factor 2 (eIF2), which 
leads to a reduction of the ER workload by attenuating global 
mRNA translation. During this time, some mRNAs are pref-
erentially translated, e.g., ATF4, which is responsible for the 
induction of several UPR target genes such as C/EBP homol-
ogous protein (CHOP; Harding et al., 1999, 2000). The third 
regulator, ATF6, translocates to the Golgi and is proteolytically 
cleaved upon activation, resulting in an active b-ZIP transcrip-
tion factor that is responsible for the induction of several UPR 
target genes (Haze et al., 1999; Adachi et al., 2008). If the ER 
stress remains unresolved, the UPR pathway will finally lead to 
the induction of apoptosis (Iurlaro and Muñoz-Pinedo, 2016).
UPR activation by intracellular bacteria. Given 
the central roles of the UPR in managing ER homeostasis and 
responding to cellular stress, it is not surprising that several 
pathogens have developed strategies to actively manipulate the 
UPR to their advantage (Table 3). Under certain instances, in-
ducing the UPR appears to actually promote bacterial replica-
tion; therefore, it is still unclear whether effector-induced UPR 
is a strategy for intracellular pathogens to increase ER folding 
capacity for their benefit, or whether this in a consequence of 
the robust defense system of the host. For example, secretion of 
LLO by L. monocytogenes activates all three branches of the 
UPR, and chemically inducing ER stress during L. monocyto-
genes infection attenuates bacterial survival (Pillich et al., 
2012). On the other hand, both Brucella melitensis and Brucella 
abortus activate branches of the UPR, and pharmacologically 
blocking the UPR during infection significantly impairs intra-
cellular replication of Brucella (Smith et al., 2013; Kees-
tra-Gounder et al., 2016). B.  melitensis infection turns on all 
three branches of the UPR (Smith et al., 2013; Fig. 2). Activa-
tion of the IRE1 branch is most likely mediated by TLRs, be-
cause XBP1u mRNA splicing is dependent on the TLR adapter 
protein myeloid differentiation primary response gene 88 
(MyD88) and still occurs when cells are treated with heat-killed 
B.  melitensis (Smith et al., 2013). However, the induction of 
UPR target genes BiP, CHOP, and ER DnaJ-like 4 (ERdj4) does 
not depend on MyD88, but instead, requires the B. melitensis 
protein TcpB (Fig. 2). Even incubating macrophages with puri-
fied TcpB protein induces UPR gene expression and restructur-
ing of the ER (Smith et al., 2013).
On the other hand, B.  abortus specifically activates the 
IRE1 branch of the UPR, but not the ATF6 or PERK branches. 
Activation of the IRE1 pathway by B. abortus up-regulates the 
machinery needed for coat protein complex II (COP II) secre-
tory vesicle formation at ER exit sites, which B. abortus uses to 
form its ER-derived replicative vacuole (Taguchi et al., 2015). 
Formation of large ER vacuoles under UPR-inducing conditions 
requires the YPT-interacting protein 1A (Yip1A), a positive reg-
ulator of IRE1. Knocking down either Yip1A or IRE1 during 
infection inhibits the intracellular replication of B. abortus, sug-
gesting that B. abortus exploits the IRE1 branch of the UPR to 
build a replicative intracellular niche (Taguchi et al., 2015).
IRE1 is activated by the B. abortus–secreted effector VceC, 
which binds to BiP inside the ER lumen (Fig. 2). In addition, 
ectopic expression of VceC induces structural reorganization of 
the ER (de Jong et al., 2013). UPR induction is concomitant 
with IRE1-dependent proinflammatory cytokine expression (de 
Jong et al., 2013). It was recently shown that VceC induces this 
proinflammatory cytokine expression through a noncanonical 
pathway that is triggered by IRE1 activation of Nod1/Nod2 
innate immune signaling (Keestra-Gounder et al., 2016). The 
expression of IL-6 is drastically reduced in cells infected with 
B.  abortus vceC mutants compared with cells infected with 
wild-type B.  abortus or cells in which Nod2 signaling is in-
duced with muramyl dipeptide (Keestra-Gounder et al., 2016). 
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In vivo studies show that necrosis is reduced and the survival of 
pups increases when mice are infected with the B. abortus vceC 
mutant (Keestra-Gounder et al., 2016). Remarkably, blocking 
the UPR with the general UPR inhibitor, tauroursodeoxycholic 
acid, during infection with wild-type B. abortus also increases 
survival and reduces necrosis, suggesting that pharmacologi-
cally inhibiting the UPR could be a viable option for treating 
B. abortus infections (Keestra-Gounder et al., 2016).
A noncanonical role of the UPR in the innate immune 
response to pathogens via cross talk with TLR and NLR sig-
naling pathways is beginning to emerge (Celli and Tsolis, 
2015). For example, activated TLR4 and TLR2 are responsi-
ble for IRE1 phosphorylation and subsequent XBP1u mRNA 
splicing (Iwakoshi et al., 2007). Remarkably, stimulating TLR4 
and TLR2 with receptor agonist activates the IRE1 pathway 
independently of chemically induced ER stress; surprisingly, 
however, TLR-dependent activation of IRE1 does not induce 
the canonical downstream ER stress response (Martinon et al., 
2010). Rather than inducing the transcription of canonical UPR 
target genes (i.e., BiP, CHOP, and ERdj4), TLR-dependent acti-
vation of IRE1 leads to elevated production of proinflammatory 
cytokines (e.g., IL-6; Martinon et al., 2010).
There is also evidence of cross talk between activated 
TLRs and the PERK arm of the UPR pathway. Stimulation of 
TLR4 by LPS increases phosphorylation of both PERK and its 
downstream target eIF2 (Woo et al., 2009). However, despite 
activation of the PERK pathway by LPS, TLR signaling blocks 
the expression of the downstream UPR target gene CHOP (Woo 
et al., 2009). TLR signaling inhibits the PERK pathway by post-
translationally modifying eIF2B, the activator of eIF2, which 
allows eIF2B to avoid competitive inhibition by phosphorylated 
eIF2 (Woo et al., 2012). Thus, although stimulation of TLRs 
activates the sensor kinases of the UPR (i.e., IRE1 and PERK), 
it appears that in most cases TLR activation inhibits expression 
of canonical UPR target genes and, instead, synergizes with 
noncanonical UPR pathways to mount a robust proinflamma-
tory response against bacterial pathogens. The molecular cross 
talk between the UPR and innate immune signaling pathways is 
only beginning to emerge and represents yet another important 
intersection of host defense against bacterial pathogens.
UPR inhibition by intracellular bacteria. Be-
cause of the especially important role of the UPR in sensing 
invading pathogens and in the defense response to bacterial in-
fection, it is not surprising that some pathogens have managed 
to figure out how to usurp UPR activation. L. pneumophila is 
one such pathogen; induction of the UPR with chemical induc-
ers of ER stress is strongly inhibited in cells infected with 
L. pneumophila (Hempstead and Isberg, 2015; Treacy-Abarca 
and Mukherjee, 2015). Inhibition of the UPR is effector medi-
ated, as the ΔdotA strain, which lacks a functional T4SS, is un-
able to block the UPR (Hempstead and Isberg, 2015; 
Treacy-Abarca and Mukherjee, 2015). Although the exact 
mechanism of inhibition is not fully understood, L. pneumoph-
ila secretes three glucosyltransferase effector proteins that 
block the IRE1 branch of the UPR by inhibiting the splicing of 
XBP1u mRNA (Hempstead and Isberg, 2015; Treacy-Abarca 
and Mukherjee, 2015; Fig. 2 and Table 2). Moreover, additional 
unknown L. pneumophila effectors inhibit the translation of BiP 
and CHOP (Treacy-Abarca and Mukherjee, 2015; Fig. 2). No-
tably, ATF6 processing, as well as the transcription of BiP and 
CHOP, increases upon L. pneumophila infection. It is unclear 
whether the translation of all of the downstream targets of ATF6 
is also suppressed, or whether L. pneumophila only selectively 
blocks the translation of BiP and CHOP. L.  pneumophila se-
cretes five effectors that are known to inhibit global protein 
translation; however, these effectors do not appear to be respon-
sible for blocking BiP translation, because the Δ5 L. pneumoph-
ila mutant that lacks these five effectors still inhibits the 
translation of BiP (Treacy-Abarca and Mukherjee, 2015). The 
translation of several UPR targets, including BiP, is controlled 
by noncanonical translation initiation factors that target up-
stream ORFs during the UPR (Starck et al., 2016). Therefore 
one possibility is that L. pneumophila effectors target these non-
canonical modes of translation; however, this possibility 
remains to be explored.
The UPR was also shown to be inhibited in cells infected 
with Simkania negevensis, an intracellular, Gram-negative bac-
terial pathogen of the order Chlamydiales (Mehlitz et al., 2014). 
Simkania-containing vacuoles form a continuous network that 
interacts extensively with the host ER. Like L.  pneumoph-
ila, S. negevensis triggers BiP transcription early in infection; 
however, BiP translation is later inhibited (Mehlitz et al., 2014; 
Fig. 2). S. negevensis also blocks the translocation of preexist-
ing CHOP protein to the nucleus (Mehlitz et al., 2014). Further-
more, phosphorylated eIF2 levels are reduced during infection, 
suggesting that S. negevensis may also inhibit the PERK-me-
diated branch of the UPR (Mehlitz et al., 2014). The ability of 
S. negevensis to inhibit the host UPR was essential for form-
ing a replicative vacuole (Mehlitz et al., 2014). Inactivation of 
PERK seems to benefit other intracellular pathogens as well. 
The inability to activate PERK because of defective eIF2 phos-
phorylation results in a higher intracellular bacterial load of 
L. monocytogenes and C.  trachomatis (Shrestha et al., 2012). 
The differences by which pathogens manipulate the UPR most 
likely reflect their specific requirements for establishing an in-
tracellular niche; some pathogens might exploit the UPR to take 
advantage of its homeostatic function (i.e., increased protein 
folding capacity and lipid biosynthesis), whereas other patho-
gens may opt to block certain branches of the UPR altogether 
to avoid its role in host defense, such as apoptosis or innate 
immunity (Celli and Tsolis, 2015). Both the degree and dura-
tion of UPR activation dictates these diverse outcomes (Walter 
and Ron, 2011). Therefore, understanding the mechanisms by 
which pathogens spatially and temporally manipulate the UPR 
could shed light on how the distinct outcomes of the UPR are 
regulated by the cell in the context of infection.
Bacterial manipulation of the 
autophagy pathway
Another crucial homeostatic process that is often targeted by 
invading pathogens to promote their survival and growth is au-
tophagy. Autophagy is a catabolic process responsible for the 
lysosomal degradation of different cytoplasmic components 
(e.g., dysfunctional organelles and proteins) to recycle and pro-
vide new building blocks for the cell. Moreover, autophagy also 
has an important role in restricting intracellular growth of many 
bacteria by a selective antipathogenic form of autophagy, called 
xenophagy. Also, in vivo studies showed that autophagy pro-
tects against the dissemination of intestinal bacteria (Benjamin 
et al., 2013). This host defense mechanism uses the autophagy 
machinery to specifically target invading pathogens for lyso-
somal degradation (Huang and Brumell, 2014).
In principle, xenophagy follows the basic steps of the au-
tophagy pathway (Fig. 3), which can be induced by a variety 
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of signals, such as the detection of invading bacteria by PRRs 
(Deretic et al., 2013; Cadwell, 2016). After induction, several 
autophagy-related (Atg) proteins are recruited to the isolation 
membrane that forms around cytoplasmic components. Ex-
pansion of the isolation membrane and formation of the dou-
ble-membrane autophagosome are mediated by ubiquitin-like 
conjugation systems that facilitate the addition of phospha-
tidyl-ethanolamine (PE) to LC3 on the isolation membrane 
(Fig.  3). The LC3–PE conjugate has a critical role in the se-
lection of the cargo. Once detected, intracellular bacteria are 
ubiquitinated by ubiquitin ligases, such as LRS AM1 and Parkin 
(Huett et al., 2012; Manzanillo et al., 2013). Ubiquitin-binding 
adapter proteins bearing an LC3-interacting region (LIR; e.g., 
p62, NBR1, NDP52, and optineurin) then direct these ubiqui-
tin-tagged bacteria to the developing autophagosome (Johansen 
and Lamark, 2011). Additionally, vacuoles containing bacteria 
can be marked for lysosomal fusion by direct recruitment of 
LC3 without ubiquitination through a noncanonical autophagy 
process called LC3-associated phagocytosis (LAP; Birgisdottir 
et al., 2013). The final step of the autophagic pathway includes 
the fusion of the autophagosome with lysosomes to generate 
the autolysosome, where bacteria are degraded by hydrolytic 
enzymes (Kimmey and Stallings, 2016; Fig. 3). Enabling au-
tophagic pathways restricts growth and proliferation of several 
intracellular bacterial pathogens. However, many intracellu-
lar bacteria have developed ways to manipulate xenophagy at 
different steps of the process to survive and replicate inside of 
the host cell (Table 4).
Evasion of xenophagy. Several studies have investi-
gated how bacteria are able to inhibit xenophagy to promote 
their intracellular growth. Some bacteria interfere with the sig-
naling cascade leading to the initiation of autophagy. One of the 
autophagy triggers is the production of ROS; likewise some 
bacteria have evolved ways to down-regulate ROS production 
(Rabadi et al., 2016). For example, the M. tuberculosis N-acet-
yltransferase effector Eis activates a JNK-specific phosphatase 
Figure 3. Modulation of the autophagy pathway by bacterial pathogens. After invasion of the host cell, vacuoles containing intracellular bacteria are tar-
geted for the autophagy machinery by ubiquitination. Adapter proteins specifically direct ubiquitinated bacteria containing vacuoles to LC3–PE conjugates 
on mature isolation membranes. The membrane expands and forms a double-membrane compartment called an autophagosome, which eventually fuses 
with lysosomes and leads to the degradation of its bacterial cargo. Several bacteria have evolved different effector proteins that inhibit (red) this selective 
autophagic immune mechanism. However, some bacterial pathogens secrete effectors that exploit this pathway (green) and make use of the generated 
nutrients and membranes to promote their intracellular growth.
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that leads to the inactivation of JNK and subsequent blocking of 
ROS production (Kim et al., 2012; Fig. 3).
One of the most crucial steps in the autophagy pathway is 
the selection of bacterial cargo by ubiquitination, which targets 
the bacteria-containing vacuole to the developing autophago-
some via interactions between ubiquitin, adapter molecules, 
and LC3-PE (Fig.  3). Several bacteria have evolved interest-
ing strategies to interfere with this critical process to promote 
escape from xenophagy at this initial step. For example, S. ty-
phimurium is able to degrade ubiquitinated protein aggregates 
that form around the Salmonella-containing vacuole (SCV), 
which would be normally recognizable by the autophagy ma-
chinery. S. typhimurium secretes the effector protein, SseL, that 
deubiquitinates ubiquitin aggregates and thereby decreases the 
recruitment of the SCV to the autophagosome by the ubiquitin–
adapter protein–LC3 interaction (Mesquita et al., 2012; Fig. 3). 
Another common strategy of autophagy evasion is the modifi-
cation of the bacterial surface to diminish ubiquitin tagging, as 
exemplified by S. flexneri or L. monocytogenes (Ogawa et al., 
2005; Yoshikawa et al., 2009; Dortet et al., 2011). Recognition 
of the S. flexneri membrane protein VirG by host Atg5 induces 
xenophagy. However, S. flexneri is able to escape xenophagy by 
secreting the effector IcsB, which binds competitively to VirG 
and thereby shields the bacterium from getting marked by Atg5 
(Ogawa et al., 2005; Fig. 3). In contrast, L. monocytogenes uses 
host proteins to camouflage its surface and escape ubiquitin 
tagging. L. monocytogenes secretes the virulence factor InlK, 
which helps to mask its cell surface by binding the mamma-
lian cytoplasmic protein major vault protein (MVP) to reduce 
ubiquitination and avoid xenophagy (Dortet et al., 2011; Fig. 3). 
Another L.  monocytogenes effector protein, ActA, mediates 
protection from xenophagy by recruiting the Arp2/3 complex 
and Ena/VASP proteins to the bacterial surface, thereby avoid-
ing recognition, ubiquitination, and the recruitment of adapter 
proteins and LC3 (Yoshikawa et al., 2009; Fig. 3). Moreover, 
expression of ActA maintains the actin-based motility and 
ability for L.  monocytogenes to disseminate within and be-
tween cells (Mostowy et al., 2011). Many pathogens that use 
actin-based motility (e.g., S. flexneri) recruit septins that assem-
ble into septin cage-like structures to entrap actin-polymerizing 
bacteria. These assemblies are recognized by the adapter pro-
teins p62 and NDP52 and subsequently targeted for autophagy 
(Mostowy et al., 2010, 2011). Mitochondria support septin-cage 
assembly; however, Shigella-induced mitochondria fragmenta-
tion leads to escape from these cages and avoidance of autoph-
agy induction (Krokowski et al., 2016).
A second common mechanism used by bacteria to avoid 
autophagic recognition is to inhibit the formation of the LC3–
PE conjugate on the autophagosome membrane. For example, 
L. monocytogenes secretes the phospholipases PlcA and PlcB 
that prevent the formation of phosphatidylinositol 3-phosphate 
(PI3P) and thereby block LC3 lipidation (Tattoli et al., 2013; 
Mitchell et al., 2015; Fig.  3). Invading bacteria also interfere 
with the metabolism of sphingolipids, a class of bioactive lipids 
that are required for LC3 lipidation and induction of autoph-
agy (Young et al., 2013). For example, L. pneumophila disrupts 
host sphingolipid metabolism by secreting the sphingosine-1 
phosphate lyase (LpSpl) that down-regulates host sphingolipid 
levels and causes a delay in the autophagic response (Rolando 
et al., 2016; Fig. 3).
However, all of the bacterial strategies to avoid xeno-
phagic degradation described here are indirect effects on the 
Table 4. Glossary of effectors: Bacterial manipulation of the autophagy pathway
Bacteria Effector Host target Target pathways Outcome Mode of action Reference
M. tuberculosis Eis JNK specific phosphatase 
(DUSP16/ MKP-7)
MAPK (i.e., JNK);  
ROS generation; 
autophagy
Inhibition of autophagy N-acetyltransferase Kim et al., 2012
S. typhimurium SseL Ubiquitin Autophagy Degradation of ubiquitinated 
protein aggregates on the SCV
DUB Mesquita et al., 2012
S. flexneri IcsB None Autophagy Camouflaging of bacterial surface 
protein VirG
Unknown Ogawa et al., 2005
L. monocytogenes InIK MVP Autophagy Camouflaging of bacterial surface 
proteins
Unknown Dortet et al., 2011
L. monocytogenes ActA Arp2/3 complex; Ena/
VASP proteins
Autophagy Recruitment of host proteins for 
camouflaging; prevention of 
septin cage formation
Unknown Yoshikawa et al., 2009; 
Mostowy et al., 2011
L. monocytogenes PlcA, PlcB PI3P Autophagy Inhibition of LC3 lipidation Phospholipases Tattoli et al., 2013; 
Mitchell et al., 2015
L. pneumophila LpSpI Sphingolipid production Autophagy Inhibition of LC3 lipidation Sphingosine-1 
phosphate lyase
Rolando et al., 2016
L. pneumophila RavZ LC3 Autophagy Cleavage of lipidated LC3 Cysteine protease Choy et al., 2012; 
Horenkamp et al., 2015; 
Yang et al., 2017
Group A 
Streptococcusa
SpeB p62, NDP52, NBR1 Autophagy Degradation of adapter proteins 
required for autophagy induction
Cysteine protease Barnett et al., 2013
A. phagocytophilum Ats-1 BECN1 Autophagy Induction of autophagosome 
formation
Unknown Niu et al., 2012;  
Niu and Rikihisa, 2013
C. burnetii Cig2 LC3 Autophagy Enhanced fusion of 
autophagosomes with the CCV
Unknown Newton et al., 2014
C. burnetii CvpB PI3P; phosphatidyl- 
inositol 5-kinase 
PIKfyve
Autophagy Enhanced association of the 
autophagy machinery to CCVs; 
homotypic fusion of CCVs
Unknown Martinez et al., 2016
aExtracellular pathogen.
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components of the autophagy machinery. To date, there are only 
a few examples of bacterial effector proteins that have a direct 
biochemical effect on a major autophagy component. One ex-
ample is the L.  pneumophila cysteine protease RavZ, which 
gets secreted by a T4SS and localizes to the autophagosome. 
RavZ extracts LC3-PE from the membrane, irreversibly cleaves 
lipidated LC3, and thereby removes it from the autophagoso-
mal membrane (Choy et al., 2012; Yang et al., 2017; Fig. 3). A 
unique combination of a PI3P binding and protease domain, as 
well as an amphipathic loop that anchors it in the autophago-
somal membrane, allows RavZ to induce a global shutdown of 
xenophagy (Horenkamp et al., 2015). Moreover, some strains of 
the extracellular Group A Streptococcus (GAS) express SpeB, a 
streptococcal cysteine protease. SpeB degrades the adapter pro-
teins p62, NDP52, and NBR1 both within the host cell cytosol 
and in vitro. By degrading autophagic adapter proteins, GAS is 
not targeted to the developing autophagosome and successfully 
escapes xenophagy (Barnett et al., 2013; Fig. 3).
Exploitation of the autophagy machinery. In 
contrast to bacteria that inhibit autophagy to secure their sur-
vival, other intracellular bacteria induce autophagy to promote 
infection. Some bacteria appear to have evolved strategies to 
hijack the autophagosomes to gain access to recycled nutrients 
that are normally used by the host cell. Indeed, the absence of 
autophagy induction can be directly correlated with an im-
paired life cycle and reduced growth for several bacte-
ria (Escoll et al., 2016).
The intracellular bacterium Anaplasma phagocytophilum 
replicates in host-derived double-membrane bound vacuoles. 
These vacuoles are similar to the autophagosomes that harbor 
LC3 and beclin-1 (BECN1), a critical protein in the induction 
of autophagy and membrane nucleation. A.  phagocytophilum 
secretes the effector protein Ats-1 into the cytoplasm, which 
directly binds BECN1 and induces autophagosome formation 
(Niu et al., 2012; Fig. 3). The induced autophagosomes are di-
rected to A.  phagocytophilum vacuoles, where they fuse and 
deliver their autophagic cargo. Thereby, A.  phagocytophilum 
acquires additional nutrients needed for its bacterial growth 
(Niu and Rikihisa, 2013).
Coxiella burnetii replicates in Coxiella-containing vac-
uoles (CCVs) that are also decorated with autophagy compo-
nents. A screen of C.  burnetii mutants to characterize genes 
required for CCV biogenesis identified the effector protein 
Cig2, which seems to enhance fusion of autophagosomes with 
the CCV (Newton et al., 2014; Fig. 3). In the proposed model, 
Cig2 promotes fusion of the CCV with autophagosomes by 
continuously maintaining LC3 on the CCV membrane. Main-
taining LC3 delays autophagosome maturation and promotes 
autophagosome fusion with other phagosomes and CCVs 
(Newton et al., 2014). This process may also be supported by 
another Coxiella effector protein, CvpB, which binds PI3P and 
perturbs the activity of the phosphatidylinositol 5-kinase PIK-
fyve, thereby enriching PI3P on CCV membranes (Martinez et 
al., 2016; Fig.  3). Increased levels of PI3P at CCVs promote 
the recruitment of autophagosomes and CCV homotypic fusion.
Bacterial modulation of mTOR signaling
One central regulator of cellular metabolism is mechanistic tar-
get of rapamycin (mTOR), which is a core component of two 
complexes: mTORC1 (containing the protein Raptor), medi-
ating cellular homeostasis, and mTORC2 (containing the pro-
tein Rictor; Martin et al., 2012). When nutrients are plentiful, 
mTORC1 is active and phosphorylates components of the au-
tophagy induction machinery, resulting in autophagy repression 
(Zoncu et al., 2011; Fig.  4). S.  typhimurium actively induces 
mTOR activation by recruiting the focal adhesion kinase (FAK) 
to the surface of Salmonella-containing vacuoles. FAK activa-
tion leads to the AKT-dependent activation of mTOR, which in 
turn inhibits autophagy (Owen et al., 2014; Fig. 4).
However, infection with pathogenic bacteria normally 
leads to a down-regulation of mTOR activity. For example, both 
S. typhimurium and S. flexneri induce amino acid starvation in 
infected epithelial cells, which results in mTOR inhibition (Tat-
toli et al., 2012). During infection with L.  pneumophila, the 
mTOR inhibition is mediated by a host-driven ubiquitination of 
positive mTOR regulators (i.e., PI3K and AKT), as well as by 
the ubiquitination of mTOR itself (Fig. 4). The down-regulation 
of mTOR by the host is dependent on the TLR adapter pro-
tein MyD88, and results in an increased expression of certain 
proinflammatory cytokines (e.g., IL-6 and IL-1β) and decreased 
expression of anti-inflammatory cytokines (e.g., IL-10; Ivanov 
and Roy, 2013; Abshire et al., 2016). Interestingly, mTOR in-
hibition is counteracted by yet unidentified, secreted L. pneu-
mophila effector proteins that activate mTOR via PI3K (Abshire 
et al., 2016). Because mTOR also controls host lipogenesis, its 
down-regulation during L. pneumophila infection leads to de-
stabilized Legionella-containing vacuoles (LCVs); however, 
effectors that activate mTOR to increase host lipogenesis would 
favor L. pneumophila replication by promoting the expansion 
of the LCV (Abshire et al., 2016). This fine-tuning of mTOR 
signaling exemplifies the complex network of interactions that 
pathogens face when they invade a mammalian cell (Fig.  4). 
Furthermore, it illustrates the need of tailoring the response of 
Figure 4. Modulation of mTOR signaling during infection. During steady-
state conditions, mTOR is a negative regulator of autophagy and inflam-
mation, as well as a positive regulator of de novo lipogenesis (black lines). 
(A) During infection, the host will inhibit mTOR signaling to activate au-
tophagy and inflammation and inhibit de novo lipogenesis. It does so by 
targeting mTOR and positive regulators of mTOR (i.e., AKT and PI3K) for 
proteasomal degradation. mTOR is also inhibited by amino acid starvation 
that occurs during infection by certain pathogens (e.g., S. typhimurium and 
S.  flexneri). Some bacterial pathogens (e.g., S.  typhimurium or L.  pneu-
mophila) activate positive regulators of mTOR signaling to counteract these 
host-driven effects and thereby improve their intracellular housing capacity. 
In the case of S. typhimurium, AKT is activated by FAK that is recruited to 
the surface of Salmonella-containing vacuoles.
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the host cell by activating and suppressing specific pathways at 
the same time to establish successful infection cycles.
Bacterial manipulation of host 
ubiquitination pathways
Ubiquitination is an important regulatory mechanism for cell 
signaling pathways. The covalent attachment of ubiquitin to 
a protein substrate is canonically an ATP-dependent enzy-
matic cascade involving three enzymes that activate ubiquitin 
(E1), conjugate ubiquitin (E2), and ligate ubiquitin (E3; Ha-
glund and Dikic, 2005). One of the reasons that ubiquitin is 
such a powerful signaling molecule is that ubiquitin itself can 
be ubiquitinated at seven distinct lysine residues to form lin-
ear or branched chains. Hence, both the degree and the linkage 
of ubiquitination influence the fate of the substrate. Poly-ubiq-
uitination on lysine 48 (UbK48) typically leads to proteasomal 
degradation of the substrate, whereas poly-ubiquitination on 
lysine 63 (UbK63) is associated with cell signaling. Typically, 
mono-ubiquitination of substrates is also associated with cell 
signaling (Haglund and Dikic, 2005). Deubiquitinases (DUBs) 
remove ubiquitin modifications and can act in a linkage-spe-
cific manner to reverse the fate of a ubiquitinated protein (Yau 
and Rape, 2016). Effectors secreted by intracellular bacteria can 
modulate the host ubiquitination pathway by mimicking host 
ubiquitination enzymes, such as E3 ubiquitin ligases and DUBs 
(Zhou and Zhu, 2015). Here we highlight a recently discovered, 
novel ubiquitination mechanism used by L.  pneumophila to 
modulate host signaling pathways.
Several groups have characterized a set of effector en-
zymes from L. pneumophila that catalyze a novel ubiquitination 
mechanism to modulate host signaling pathways (Sheedlo et 
al., 2015; Bhogaraju et al., 2016; Qiu et al., 2016; Kotewicz et 
al., 2017; Table 5). The SidE effector family (i.e., SidE, SdeA, 
SdeB, and SdeC) is important for the intracellular replication of 
L. pneumophila in amoeba (Qiu et al., 2016). Unlike canonical 
ubiquitination pathways, where E1, E2, and E3 enzymes use ATP 
to ubiquitinate lysine residues of their target substrate, members 
of the SidE family are unique in that they possess domains that 
confer multiple enzymatic functions used for ubiquitination 
into a single effector and do not require ATP (Fig. 5). Instead, 
a mono-ADP-ribosyltransferase domain allows members of the 
SidE effectors to use NAD+ to posttranslationally modify host 
ubiquitin with a phosphoribose moiety on arginine 42 to gen-
erate ADP-ribosylated ubiquitin (ADPR-Ub; Qiu et al., 2016). 
The collective action of the a nucleotidase/phosphohydrolase/
phosphodiesterase domain then cleaves ADPR-Ub into AMP 
and a phosphoribosylated ubiquitin (PR-Ub) and covalently at-
taches PR-Ub to host proteins via a noncanonical serine-linked 
phosphodiester bond (Bhogaraju et al., 2016; Qiu et al., 2016; 
Kotewicz et al., 2017). Members of the SidE effector family also 
contain a DUB domain that can remove ubiquitin modifications 
imparted by the canonical host ubiquitination machinery with-
out interfering with the SidE-mediated ubiquitination (Sheedlo 
et al., 2015). In addition, the DUB activity of SidE effectors 
reduces the level of ubiquitination on the surface of the LCV 
(Sheedlo et al., 2015). Moreover, the activity of the SidE effector 
family also generates a pool of PR-Ub that impairs conventional 
host ubiquitination pathways by interfering with host E1 and E2 
enzymes when overexpressed in either mammalian or yeast cells 
(Bhogaraju et al., 2016; Kotewicz et al., 2017). Overexpressing 
members of the SidE effector family (i.e., SdeA) also interferes 
Table 5. Glossary of effectors: Bacterial manipulation of host ubiquitination pathways
Bacteria Effector Host target Target pathways Outcome Mode of action Reference
L. pneumophila SidE effector 
family 
Rabs; Reticulon 4 UbDCPa Inhibition of mitophagy,b innate 
immunity,b proteasomal 
degradation,b membrane 
trafficking, ER structure
Ubiquitin 
ligase/DUB
Sheedlo et al., 2015; 
Bhogaraju et al., 2016; 
Qiu et al., 2016; 
Kotewicz et al., 2017
L. pneumophila SidJ SidE-ubiquitinated 
substrates; host-ubiq-
uitinated substrates
UbDCP Removes ubiquitination left by 
the host as well as from SidE 
effector family
DUB Qiu et al., 2017
aUbDCP, ubiquitination-dependent cellular processes.
bResults from overexpression of SidE effector family member.
Figure 5. Ubiquitination of host proteins by Legionella SidE effector fam-
ily. The SidE family of effectors from L. pneumophila modify host ubiquitin 
and ubiquitinate host proteins using a novel catalytic mechanism. The DUB 
domain of SidE effectors does not interfere with SidE-mediated ubiquiti-
nation, but instead, removes ubiquitin imparted by the canonical ubiq-
uitination machinery of the host. It is unclear whether the DUB activity 
acts to generate a pool of ubiquitin and/or a pool of host target pro-
tein substrates for SidE effectors. The mono-ADP-ribosyltransferase (mART) 
domain uses NAD+ to attach a phosphoribose moiety to arginine 42 of 
host ubiquitin, which generates ADP-ribosylated ubiquitin (ADPR-Ub) and 
nicotinamide (NAA). ADPR-Ub is further cleaved into phosphoribosylated 
ubiquitin (PR-Ub) and AMP by the nucleotidase/phosphohydrolase/phos-
phodiesterase (NP/PDE) domain. PR-Ub is covalently attached to host pro-
teins via a noncanonical serine-linked phosphodiester bond. This novel 
ubiquitination mechanism does not require E1, E2, or E3 enzymes or ATP 
from the host. The generated pool of PR-Ub also disrupts canonical host 
ubiquitination machinery.
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with several ubiquitin-regulated processes in the host, including 
mitophagy, immunity (i.e., TNF-induced NF-κB nuclear trans-
location), and proteasomal degradation (i.e., constitutive degra-
dation of hypoxia inducing factor 1α (Bhogaraju et al., 2016). 
Furthermore, members of the SidE effector family facilitate 
LCV biogenesis by targeting both Rabs and the ER-resident re-
ticulon family of proteins to modulate host membrane trafficking 
and ER structure, respectively (Bhogaraju et al., 2016; Qiu et 
al., 2016; Kotewicz et al., 2017). Remarkably, L. pneumophila 
also secretes a DUB effector, SidJ, which reverses the ubiquitin 
modification imparted by members of the SidE effector family, 
thereby ensuring that the effects of these ubiquitin modifica-
tions are temporally regulated (Qiu et al., 2017). SidJ removes 
not only PR-Ub moieties left by the SidE effector family, but 
also ubiquitin modifications left by the canonical mammalian 
ubiquitination machinery (Qiu et al., 2017). Overall, this novel 
ubiquitination mechanism represents a potent weapon in the ar-
senal of Legionella effectors that can be deployed with temporal 
precision to manipulate host cell signaling pathways.
Conclusions and future perspectives
Intracellular bacteria are challenged with maintaining a delicate 
balance of weakening their host to prevent clearance, while at 
the same time keeping their host healthy enough to establish a 
suitable niche for intracellular replication. They modulate host 
intracellular signaling pathways in their favor to both shuttle 
resources to their replicative vacuoles and disarm host defense 
mechanisms. Dissecting the molecular mechanisms of this nev-
er-ending battle has the potential to strongly impact our under-
standing of host evasion by pathogens, as well as greatly expand 
our knowledge of host defense pathways.
We have described a diverse array of bacterial effectors 
that have been shaped by evolution to mimic host enzymes, 
as well as effectors that perform novel enzymatic activities, to 
modulate innate immunity, the UPR, and autophagic signaling 
pathways of their hosts. Using intracellular bacteria to probe 
the many ways in which kinase cascades, ubiquitin cascades, 
and epigenetic gene regulation can be modulated will serve as a 
powerful tool moving forward as the field continues to untangle 
these signaling pathways. The complexity and the precise coor-
dination orchestrated by bacteria to modulate host cell signal-
ing are astonishing. We have explored how bacterial pathogens 
can target different pathways simultaneously or even one path-
way with several effectors. Moreover, different bacteria have 
developed remarkably innovative and individualized strategies 
to target the same host cell signaling pathways. This shows 
the overwhelming variety in bacterial effectors that have been 
discovered to date, and highlights the importance of studying 
bacterial effector proteins to reveal novel enzymatic activities 
that can regulate host cell signaling. Furthermore, the crosstalk 
between the different signaling pathways is only just beginning 
to be elucidated and adds another layer of complexity.
Pathogens, in many ways, are nature’s cell biologists. Re-
search into how pathogens rewire host intracellular signaling 
pathways is central to understanding infectious diseases and 
comprises an exciting interdisciplinary field by combining mi-
crobiology, cell biology, biochemistry, and immunology. A bet-
ter understanding of the survival strategies used by intracellular 
pathogens will prove useful for the rational design of novel ap-
proaches and therapies to fight infectious diseases and will pro-
vide a deeper insight into the inner workings of our own cells.
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